Insider Shareholders with Indirect Ownership of Pandion Therapeutics, Inc. (PAND)
This section provides a comprehensive overview of the insiders with indirect ownership of Pandion Therapeutics, Inc. (PAND). You can find the latest updates on their holdings.
Pandion Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | # of Trades |
|---|---|---|---|
|
Boxer Capital, Llc
> 10% Shareholder |
23,622 | 0 | 1 |
|
Glaxosmithkline Plc
Director |
2,248,304 | 0 | 1 |
|
Ra Capital Management, L.P.
> 10% Shareholder |
1,770,023 | 0 | 1 |
|
Daniel J. Becker
Director |
227,110 | 2,827,883 | 4 |
|
Rahul Kakkar
Chief Executive Officer |
0 | 702,515 | 1 |
|
Joanne L. Viney
Officer |
0 | 1,200 | 1 |
|
Alan L Crane
Director |
0 | 3,537,736 | 1 |
|
Gregg Beloff
Officer |
0 | 13,196 | 1 |
|
Christopher Fuglesang
Director |
0 | 2,131,135 | 1 |
|
Nancy Stagliano
Director |
0 | 73,067 | 1 |
|
Jill Carroll
Director |
0 | 5,674,221 | 1 |